Next 10 |
2024-04-25 17:49:16 ET Summary The Annual Meeting of the American Society of Clinical Oncology is a major event for clinicians and researchers in the field of oncology. The plenary session will feature presentations on topics such as esophageal cancer, melanoma, and lung cancer. ...
2024-04-23 18:25:09 ET Scooting past analyst estimates for its latest quarter gave Novartis (NYSE: NVS) a lift on Tuesday. Investors like what they heard about the global healthcare company's inaugural earnings release for 2024, and rewarded Novartis with a more than 2% lift in its ...
2024-04-23 15:00:03 ET Wan Nurhayati from CFRA issued a price target of $108.00 for NVS on 2024-04-23 13:11:00. The adjusted price target was set to $108.00. At the time of the announcement, NVS was trading at $97.27. NVS currently trades -10.58% versus its 52 week high ...
2024-04-23 14:08:57 ET More on Novartis Novartis AG (NVS) Q1 2024 Earnings Call Transcript Novartis: Strong Start To The Year With Beat-And-Raise First Quarter Results Novartis AG 2024 Q1 - Results - Earnings Call Presentation Biggest stock movers today: SPOT...
2024-04-23 13:32:13 ET More on Sanofi Sanofi: My Top Pick In Big Pharma Sanofi (SNY) Barclays 26th Annual Global Healthcare Conference (Transcript) Sanofi (SNY) Leerink Partners Global Biopharma Conference (Transcript) Sanofi succeeds in late-stage trial for ...
2024-04-23 11:55:26 ET Novartis AG (NVS) Q1 2024 Earnings Conference Call April 23, 2024, 08:00 AM ET Company Participants Sloan Simpson - Head of Investor Relations Vas Narasimhan - Chief Executive Officer Harry Kirsch - Chief Financial Officer Conference ...
2024-04-23 11:15:11 ET Image source: The Motley Fool. Novartis Ag (NYSE: NVS) Q1 2024 Earnings Call Apr 23, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Novartis Ag (NVS) Q1 2024 Earnings Call Transcript
2024-04-23 10:00:00 ET Summary Novartis reported strong first quarter results with an EPS beat and revenue beat. The company's core growth products, including Entresto, Cosentyx, Kesimpta, Kisqali and Leqvio, drove the strong first-quarter performance. Novartis increased its f...
Kiniksa Pharmaceuticals Ltd. (KNSA) is expected to report $-0.14 for Q1 2024 Agree Realty Corporation (ADC) is expected to report $1.01 for Q1 2024 1st Colonial Bancorp Inc (FCOB) is expected to report for Q1 2024 Equity Residential of Beneficial Interest (EQR) is expected to report $...
2024-04-23 05:15:48 ET More on related stocks: Novartis Looks To Get Back On Track With Q1 Earnings Arvinas And Novartis Partnering On Prostate Cancer Protein Degrader Is A Win-Win Situation Nucor: A Solid Start To 2024 Novartis beats top-line and bottom-line...
News, Short Squeeze, Breakout and More Instantly...
Novartis AG Company Name:
NVS Stock Symbol:
NYSE Market:
GSK Plc (NYSE:GSK) has reportedly taken legal action against Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) in a...
Tuesday, Novartis AG (NYSE:NVS) received FDA approval for its Lutathera (lutetium Lu 177 dotatate / INN: lu...
2024-04-23 18:25:09 ET Scooting past analyst estimates for its latest quarter gave Novartis (NYSE: NVS) a lift on Tuesday. Investors like what they heard about the global healthcare company's inaugural earnings release for 2024, and rewarded Novartis with a more than 2% lift in its ...